
Enselin 8mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Rosiglitazone (8mg)
Overview Enselin 8mg Tablet
Diabetace 8mg tablets are indicated for managing type 2 diabetes in adults. This medication assists in regulating blood glucose, thus mitigating the risk of serious diabetic complications such as renal impairment and vision loss. Diabetace 8mg may be administered independently or concurrently with other therapies, with or without food. Consistent daily dosing at the same time maximizes efficacy. Dosage adjustments are determined by your physician based on treatment response. Continued use is crucial even with controlled blood sugar or well-being; premature cessation can lead to elevated glucose levels, increasing the probability of kidney disease, blindness, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan including a balanced diet, regular physical activity, and weight management as prescribed. Lifestyle choices significantly impact diabetes control. Common adverse reactions include visual disturbances, paresthesia, and bone fractures. Consult your physician if these symptoms are bothersome or persistent. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Prior to commencing treatment, inform your doctor of any history of cardiovascular disease, thyroid disorders, or endocrine imbalances; suitability may be affected. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Enselin 8mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Enselin 8mg Tablet
Managing Type 2 diabetes
Major Benefits of Enselin 8mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Enselin 8mg Tablet can be consumed with or without food, though consistent daily timing is recommended.
Common Side effects of Enselin 8mg Tablet:
- Blurred vision
- Numbness
- Bone fracture
- Respiratory tract infection
How to use Enselin 8mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Enselin 8mg Tablet can be consumed with or without food, although consistent timing is recommended.
How Enselin 8mg Tablet works:
GlucoSense 8mg tablets are used to manage diabetes. Their mechanism of action involves enhancing the body's responsiveness to insulin, thereby regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Enselin 8mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Enseline 8mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Enselin 8mg Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Enselin 8mg Tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment can safely use Enselin 8mg tablets without requiring any modification to the prescribed dosage.
LiverCAUTION
Patients with hepatic impairment should use Enselin 8mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Report any jaundice symptoms to your doctor during treatment.
What if you forget to take Enselin 8mg Tablet :
Omit any missed Enselin 8mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Enselin 8mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Thiazolidinedione-based compound |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Active Class | PPAR-gamma agonist (thiazolidinedione) |
